My body needed the GLP-1 and clinical support," said Williams
The highest doses studied 8 mg and 12 mg were associated with the greatest weight loss outcomes in trial data, but also with a higher incidence of side effects
While GLP-1 medications have been approved as treatments for children with type 2 diabetes since 2019, pediatric prescriptions spiked after Wegovys high-profile FDA approval for adolescents in December 2022, which specified that it can be used for weight loss
Standard lymphoedema management includes decongestive lymphatic therapy, compression, skin care, and exercise
[See Adverse Reactions.] Macrovascular Outcomes There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Janumet or any other anti-diabetic drug
Injection site rotation: Rotate between abdomen, front of thighs, and back of upper arms